Target intelligence / Profile preview

TonB-dependent siderophore transporter (TBDR)

Target
TBDR
Molecular classification
Transporter, Outer membrane protein, Porin-like protein
01

Overview

TonB-dependent siderophore transporters are essential outer membrane proteins in Gram-negative bacteria that facilitate the active uptake of iron-siderophore complexes from the extracellular environment [1]. Because free iron is extremely scarce within a host due to sequestration by proteins like transferrin, bacteria secrete small molecules called siderophores to scavenge iron; these transporters then recognize and internalize the iron-laden complexes using energy derived from the inner membrane TonB-ExbB-ExbD system [1,3]. In the context of drug development, these transporters are the primary targets for "Trojan horse" antibiotics, most notably Cefiderocol, which features a catechol moiety that mimics natural siderophores [2]. This mechanism allows the antibiotic to bypass traditional resistance pathways, such as porin loss or efflux pump overexpression, by being actively transported into the periplasmic space where it can inhibit cell wall synthesis [2]. These transporters are critical for the survival and virulence of multidrug-resistant pathogens, including Pseudomonas aeruginosa, Acinetobacter baumannii, and Carbapenem-resistant Enterobacteriaceae [2,3]. Sources: [1] Noinaj et al. (2010) Nature Reviews Microbiology; [2] Zhanel et al. (2019) Drugs; [3] Holden and Bachman (2015) Annals of the American Thoracic Society.

Other names
Ferric-siderophore receptorOuter membrane siderophore transporterTonB-dependent receptorSiderophore-iron transporterIron-siderophore uptake protein
02

Mechanism of action

Siderophore-mediated active transport (Trojan horse mechanism) where the drug mimics a ferric-siderophore complex to be actively pulled into the bacterial periplasm via the transporter.

03

Biological functions

Iron acquisitionActive transportBacterial homeostasisNutrient uptakeBacterial virulence
04

Disease associations

InfectionSepsisPneumoniaUrinary tract infectionBacteremia
05

Safety considerations

Development of resistance through transporter mutation or downregulationMutations in the TonB-ExbB-ExbD energy-coupling complexPotential for reduced drug uptake in iron-replete environmentsCross-resistance with other siderophore-conjugated antibiotics
06

Interacting drugs

Cefiderocol

3 more in the full profile.

07

Biomarkers

CirA expressionFiu expressionPiuA expressionBacterial iron-starvation responseTonB system activity

Beyond the preview

Go deeper on TonB-dependent siderophore transporter (TBDR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TonB-dependent siderophore transporter (TBDR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call